Truvada Approval History 
- FDA approved: Yes (First approved August 2nd, 2004)
- Brand name: Truvada
- Generic name: emtricitabine and tenofovir
- Company: Gilead Sciences, Inc.
- Treatment for: HIV Infection
Truvada (emtricitabine and tenofovir disoproxil fumarate) is a combination of nucleoside analog HIV-1 reverse transcriptase inhibitors indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
FDA Approval History for Truvada
| Date | Article |
|---|---|
| Jul 16, 2012 |  FDA Approves Truvada for Reducing the Risk of Sexually Acquired HIV Infection |
| Aug 2, 2004 | Truvada Gilead Sciences, Inc. - Treatment for HIV Infection |
See also...
Truvada (emtricitabine and tenofovir) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
